Research Articles | Page 83 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes Mar 2015 Leukemia myelodysplastic syndromes (MDS)
Immunomodulation With Pomalidomide at Early Lymphocyte Recovery After Induction Chemotherapy in Newly Diagnosed AML and High-Risk MDS Jun 2020 Leukemia acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry Sep 2015 Leukemia myelodysplastic syndromes (MDS)
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes Feb 2018 Leukemia myelodysplastic syndromes (MDS)
Characterization of Myelodysplastic Syndromes (MDS) With T-cell Large Granular Lymphocyte Proliferations (LGL) Jun 2020 Leukemia myelodysplastic syndromes (MDS)
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents Nov 2013 Leukemia myelodysplastic syndromes (MDS)
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes May 2014 Leukemia myelodysplastic syndromes (MDS)
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla Feb 2015 Leukemia myelodysplastic syndromes (MDS)
Application of the International Prognostic Scoring System-Revised (IPSS-R) in Therapy-related Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia. Jun 2013 Leukemia myelodysplastic syndromes (MDS)
Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients Jul 2020 Leukemia myelodysplastic syndromes (MDS)